HCV NS3 1436-1444 mutant (HLA-A*01:01) 1444Y
( ATDALMTGY )
- Description ATDALMTGY is a linear peptidic epitope (epitope ID4917) studied as part of Genome polyprotein from Hepatitis C virus. This e… More
- TechData ATDALMTGY is a linear peptidic epitope (epitope ID4917) studied as part of Genome polyprotein from Hepatitis C virus. This e… More
- Documents ATDALMTGY is a linear peptidic epitope (epitope ID4917) studied as part of Genome polyprotein from Hepatitis C virus. This e… More
- References
ATDALMTGY is a linear peptidic epitope (epitope ID4917) studied as part of Genome polyprotein from Hepatitis C virus. This epitope has been studied for immune reactivity, tested in T cell assays and MHC ligand assays
| Sequence: | ATDALMTGY | |
| Delivery: | 3 weeks | |
| C-Terminus: | OH | |
| N-Terminus: | H | |
| Amount: | 1 mg | |
| Counter Ion: | TFA | |
| Protein: | Genome polyprotein | |
| Species: | Hepatitis C virus (HCV) | |
| Allele: | HLA-A*01:01 | |
| Application : | T-cell assays, Immune monitoring, Antigen specific T-cell stimulation, T-cell expansion, Cellular immune response | |
| Indication : | Infectious disease | |
| Purity : | 95% HPLC-MS |
Protocols and Tips
Data sheets
Safety data sheet poly peptides:For your convenience, we have compiled a selection of publications
where our peptide products have been employed:
Publications >
€105.00*
sterile and endotoxin free
Delivery Format: The product is supplied freeze dried.
Purity: 95% HPLC-MS
More HCV peptides